Correlation Between Corline Biomedical and Integrum

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corline Biomedical and Integrum at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corline Biomedical and Integrum into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corline Biomedical AB and Integrum AB Series, you can compare the effects of market volatilities on Corline Biomedical and Integrum and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corline Biomedical with a short position of Integrum. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corline Biomedical and Integrum.

Diversification Opportunities for Corline Biomedical and Integrum

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Corline and Integrum is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Corline Biomedical AB and Integrum AB Series in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrum AB Series and Corline Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corline Biomedical AB are associated (or correlated) with Integrum. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrum AB Series has no effect on the direction of Corline Biomedical i.e., Corline Biomedical and Integrum go up and down completely randomly.

Pair Corralation between Corline Biomedical and Integrum

Assuming the 90 days trading horizon Corline Biomedical AB is expected to generate 0.84 times more return on investment than Integrum. However, Corline Biomedical AB is 1.19 times less risky than Integrum. It trades about -0.02 of its potential returns per unit of risk. Integrum AB Series is currently generating about -0.07 per unit of risk. If you would invest  1,420  in Corline Biomedical AB on November 8, 2024 and sell it today you would lose (405.00) from holding Corline Biomedical AB or give up 28.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.6%
ValuesDaily Returns

Corline Biomedical AB  vs.  Integrum AB Series

 Performance 
       Timeline  
Corline Biomedical 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Corline Biomedical AB are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Corline Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point.
Integrum AB Series 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrum AB Series has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Corline Biomedical and Integrum Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corline Biomedical and Integrum

The main advantage of trading using opposite Corline Biomedical and Integrum positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corline Biomedical position performs unexpectedly, Integrum can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrum will offset losses from the drop in Integrum's long position.
The idea behind Corline Biomedical AB and Integrum AB Series pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals